| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.7B | $11.2B | $11.2B | $10.4B | $9.0B | $2.2B | $2.1B | $2.0B |
| Cost of Revenue | $7.8B | $5.9B | $6.2B | $5.9B | $4.9B | $4.4B | $4.4B | $4.2B |
| Gross Profit | $3.9B | $5.3B | $5.0B | $4.5B | $4.0B | $1.0B | $0.9B | $0.9B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $2.5B | $2.4B | $2.4B | $2.2B | $2.0B | $1.9B | $1.9B | $1.9B |
| Operating Income | $1.4B | $2.9B | $2.6B | $2.3B | $2.0B | $1.8B | $1.6B | $1.6B |
| Net Income | $0.9B | $2.2B | $1.9B | $1.6B | $1.5B | $0.3B | $0.2B | $0.3B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.7B | $12.9B | $11.9B | $10.9B | $10.4B | $9.1B | $8.1B | $7.7B |
| Current Assets | $3.6B | $3.8B | $2.9B | $2.6B | $2.2B | $3.0B | $2.1B | $2.2B |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.6B |
| Total Liabilities | $9.1B | $8.2B | $7.8B | $7.6B | $7.7B | $6.9B | $6.4B | $6.3B |
| Current Liabilities | $3.0B | $3.9B | $3.0B | $3.3B | $2.5B | $1.9B | $2.0B | $2.4B |
| Stockholders' Equity | $4.6B | $4.7B | — | — | $2.8B | $2.2B | $1.7B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $2.5B | $2.3B | $2.3B | $2.1B | $1.7B | $1.8B | $1.6B |
| Investing Cash Flow | $-1.3B | $-1.0B | $-1.2B | $-0.8B | $-2.2B | $-0.5B | $-0.8B | $-1.5B |
| Capital Expenditures | $0.5B | $0.6B | $0.8B | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B |
| Financing Cash Flow | $-0.8B | $-1.3B | $-1.1B | $-1.4B | $-0.7B | $-0.5B | $-1.1B | $0.1B |